In a real-world study of the interlukin-23p inhibitor guselkumab, a substantial number of patients with IBD achieved ...

Capsule endoscopy assisted by an artificial intelligence platform significantly enhanced the detection of small bowel ulcers ...

Participation in endurance sports was associated with a threefold increase in the risk for ischemic colitis and increased ...

In this edition of MicroBiome Zone, Elena Ivanina, DO, MPH, explores the relationship between gut microbiota and longevity, ...

A total of 9,567 PCAB initiators and 3,597,933 PPI initiators were identified. For the PCAB and PPI initiators, the average ages were 53 and 55 years, respectively, 67% and 62% were female, 44% and 38 ...

IBS-C is defined by the presence of recurrent abdominal pain associated with defecatory symptoms. The Rome IV criteria were updated in June to Rome V, and require pain at least one day per week ...

The FDA has approved lirafugratinib (Lyrfigtu, Elevar) for the treatment of adults with previously treated unresectable, locally advanced, or metastatic cholangiocarcinoma harboring a fibroblast ...

In this installment of our video series Through the Scope, Rajesh Keswani, MD, MS, demonstrates the importance of careful ...

A daily dose of aspirin led to a significant reduction in liver fat in patients with metabolic dysfunction–associated steatotic liver disease, according to new research.

Being diagnosed with inflammatory bowel disease often leads to isolation, shame, and a lot of potentially embarrassing questions.

Higher preoperative abundance of the periodontal pathogenic bacterium Porphyromonas was associated with an increased risk for recurrence in patients with early-stage colorectal cancer undergoing ...